Goldman Sachs has initiated coverage of Vera Therapeutics (VERA) with a buy rating, citing its drug candidate atacicept and a ...
Goldman Sachs analyst Paul Choi initiated coverage of Vera Therapeutics (VERA) with a Buy rating and $58 price target Following the recent ...
Goldman Sachs analysts revised their model so that it includes Tesla's Full Self Driving (FSD) capabilities and robotaxi revenues in the forecast for 2027. The firm also made some big strides in ...
LONDON, Jan 16 (Reuters) - Investors have been hoping Donald Trump's return to the White House next week will boost the U.S. stock market, while Goldman Sachs sees stocks benefiting from the ...
Goldman Sachs CEO David Solomon Revenue in Goldman's asset and wealth management arm climbed 8% to $4.72 billion, while revenue at its global banking and markets division increased by 33% to $8.48 ...
Goldman Sachs' Q4 2024 earnings per share (EPS) soared to $11.95, significantly surpassing the expected $8.21. Revenue in Q4 hit $13.87 billion, exceeding estimates of $12.36 billion. Fourth ...
Jan 13 (Reuters) - Goldman Sachs (GS.N), opens new tab on Monday announced plans to combine key business segments under a single unit named 'Capital Solutions Group,' to grow in private credit ...
As Vera concluded its 14th and final series on ITV, fans bidded a fond farewell to crime-solving led by Brenda Blethyn as DCI Vera Stanhope. Equally as compelling as the drama are the ...
FANS of Vera have been left convinced the ITV show will launch a brand new spin-off series after a very telling clue. The iconic crime drama, starring actress Brenda Blethyn, drew to a close after ...
Goldman Sachs analyst Lizzie Dove says that Norwegian Cruise Line is in a strong position to have in the premium cruise segment. HundredX data points to an accelerating Net Purchase Intent (NPI ...
Goldman Sachs cuts Tesla’s 2025 delivery forecast to 2.01M, well below Tesla’s 20%-30% growth target. FSD v13 shows improvements, but Goldman expects limited robotaxi service launch in 12-24 ...